Clinical trial Recruiting at 3 sites Observational Ages 18 and up

Smart lung support for adults on a ventilator in the ICU

Official title: Intelligent Lung Support in the Intensive Care Unit (IntelliLung): An Observational, Prospective, Multicentre Study

Run by Technische Universität Dresden · NCT06595602 · Data updated 2026-11-12

This observational project will test the IntelliLung AI decision support system in adults receiving invasive mechanical ventilation to see if its recommended ventilator settings match what clinicians actually choose.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment530 (estimated)
SponsorTechnische Universität Dresden
Academic / other
Locations5 sites (Dresden and 4 other locations)
StatusRecruiting
StartedMay 25, 2025
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedJuly 2, 2026
Trial IDNCT06595602 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults (≥18 years) who are invasively mechanically ventilated, expected to remain intubated for more than 24 hours, and who (or whose proxy) can provide informed consent.

Probably not a fit

Patients expected to die within 48 hours, those on closed-loop ventilation modes, participants in interventional mechanical ventilation trials, or persons unable to consent (including prisoners) are unlikely to receive benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter observational effort runs the IntelliLung artificial-intelligence decision support software in parallel with routine care for adults on invasive mechanical ventilation, including patients with and without ARDS and those receiving extracorporeal lung support. The system generates ventilator-setting recommendations while clinicians retain final decision-making authority; researchers will record the clinician-selected settings and the AI recommendations. The main analysis quantifies concordance between clinician settings and IntelliLung recommendations and explores factors associated with agreement or disagreement. Data are collected across participating centers in Germany, Italy, and Poland to describe real-world performance and acceptability.

Why it matters

Potential benefit: If successful, IntelliLung could help standardize ventilator settings and reduce ventilator-induced lung injury, potentially improving patient outcomes.

How similar studies have gone: Prior feasibility and algorithm-development work on AI-based ventilator decision support has shown promise in simulations and small single-center series, but robust multicenter clinical outcome data are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male and female patients, age ⪰18 years
2. Written informed consent
3. Invasively mechanically ventilated patients expected to be intubated for more than 24 hours.

Exclusion Criteria:

1. Expected to die within ≤48 hours
2. Participation in an interventional mechanical ventilation trial
3. Mechanical Ventilation with a closed-loop ventilation mode
4. Persons dependent on the sponsor and/or investigator
5. Subjects who are currently imprisoned or otherwise in confinement ordered by law or other official authorities

Where it's running

  • Department of Anesthesiology and Intensive Care Medicine, Pulmonary Engineering Group, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany
    Dresden, Germany
    Recruiting
  • Department of Anaesthesiology and Intensive Care, National Medical Institute of the Ministry of Interior and Administration, Warsaw, Poland
    Warsaw, Poland
    Recruiting
  • Critical Care Department, Parc Taulí Hospital Universitari, Institut d'Investigació I Innovació Parc Taulí (I3PT-CERCA), Sabadell, Spain
    Sabadell, Spain
    Recruiting
  • Dipartimento di Scienze Chirurgiche e Diagnostiche Integrate, University of Genoa, Genoa, Italy
    Genova, Italy
    Not yet recruiting
  • Department of Intensive Care Medicine. Hospital Universitario de La Princesa. Universidad Autonoma de Madrid, Madrid, Spain
    Madrid, Spain
    Not yet recruiting

Study contacts

  • Principal investigator: Jakob Wittenstein — epartment of Anesthesiology and Intensive Care Medicine, Pulmonary Engineering Group, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany
  • Study coordinator: Jakob Wittenstein, M.D.
  • Email: jakob.wittenstein@ukdd.de
  • Phone: +49 351 458 19777

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.